We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,214
Reduced
3,562
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCTL
8776
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$7.83K ﹤0.01%
+5,254
New +$8.25K
ITP icon
8777
IT Tech Packaging
ITP
$3.04M
$7.8K ﹤0.01%
16,959
+2,991
+21% +$2K
THRN
8778
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$7.8K ﹤0.01%
+2,148
New +$9.52K
FCRD
8779
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$7.8K ﹤0.01%
1,830
-2,981
-62% -$12.3K
RSPE icon
8780
Invesco ESG S&P 500 Equal Weight ETF
RSPE
$69.2M
$7.79K ﹤0.01%
359
+31
+9% +$666
BWAQU
8781
DELISTED
Blue World Acquisition Corporation Unit
BWAQU
$7.79K ﹤0.01%
761
+100
+15% +$1.02K
ESLA icon
8782
Estrella Immunopharma
ESLA
$32.1M
$7.78K ﹤0.01%
756
+310
+70% +$3.15K
MTRY
8783
DELISTED
Monterey Innovation Acquisition Corp. Common Stock
MTRY
$7.77K ﹤0.01%
740
-1,700
-70% -$17.5K
EEX
8784
DELISTED
Emerald Holding
EEX
$7.76K ﹤0.01%
2,193
-1,858
-46% -$6.67K
RGLS
8785
DELISTED
Regulus Therapeutics
RGLS
$7.76K ﹤0.01%
5,662
-4,514
-44% -$7.1K
MXE
8786
Mexico Equity and Income Fund
MXE
$57.9M
$7.75K ﹤0.01%
883
AILG
8787
DELISTED
Alpha Intelligent Large Cap Growth ETF
AILG
$7.75K ﹤0.01%
+500
New +$7.84K
STXF
8788
Strive 500 ETF
STXF
$1.16B
$7.74K ﹤0.01%
+319
New +$7.8K
PETV
8789
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
$7.72K ﹤0.01%
3,938
-1,252
-24% -$2.92K
JZ
8790
Jianzhi Education Technology Group
JZ
$6.09M
$7.71K ﹤0.01%
12
+6
+100% +$8.35K
FDIG icon
8791
Fidelity Crypto Industry and Digital Payments ETF
FDIG
$252M
$7.7K ﹤0.01%
737
-240
-25% -$3.06K
SBEV icon
8792
Splash Beverage Group
SBEV
$2.81M
$7.69K ﹤0.01%
50
+45
+900% +$7.89K
WIX icon
8793
CALL
WIX.com
WIX
$2.55B
$7.68K ﹤0.01%
+100
New +$8.08K
DALS
8794
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$7.68K ﹤0.01%
776
+600
+341% +$5.91K
MOBX icon
8795
Mobix Labs
MOBX
$26M
$7.68K ﹤0.01%
75
-2
-3% -$203
GPUS
8796
Hyperscale Data Inc
GPUS
$54.1M
0
KUKE
8797
DELISTED
Kuke Music
KUKE
$7.67K ﹤0.01%
1,446
+1,120
+344% +$6.44K
TANH icon
8798
Tantech Holdings
TANH
$6.07M
$7.67K ﹤0.01%
89
+4
+5% +$478
SCMAU
8799
DELISTED
Seaport Calibre Materials Acquisition Corp. Unit
SCMAU
$7.66K ﹤0.01%
750
PPYAU
8800
DELISTED
Papaya Growth Opportunity Corp. I Unit
PPYAU
$7.65K ﹤0.01%
750

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.